Medpace Financial Statements From 2010 to 2025
| MEDP Stock | USD 557.90 8.25 1.46% |
Check Medpace Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medpace Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . Medpace financial statements analysis is a perfect complement when working with Medpace Holdings Valuation or Volatility modules.
Check out the analysis of Medpace Holdings Correlation against competitors. Medpace Holdings Company Return On Asset Analysis
Medpace Holdings' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medpace Holdings Return On Asset | 0.17 |
Most of Medpace Holdings' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medpace Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medpace Holdings has a Return On Asset of 0.1652. This is 101.89% lower than that of the Life Sciences Tools & Services sector and 102.19% lower than that of the Health Care industry. The return on asset for all United States stocks is notably lower than that of the firm.
Medpace Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medpace Holdings's current stock value. Our valuation model uses many indicators to compare Medpace Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medpace Holdings competition to find correlations between indicators driving Medpace Holdings's intrinsic value. More Info.Medpace Holdings is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.22 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medpace Holdings is roughly 4.46 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Medpace Holdings by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Medpace Holdings Financial Statements
Medpace Holdings shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Medpace Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in Medpace Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on Medpace Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company was founded in 1992 and is based in Cincinnati, Ohio. Medpace Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5000 people.
Pair Trading with Medpace Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medpace Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will appreciate offsetting losses from the drop in the long position's value.Moving together with Medpace Stock
Moving against Medpace Stock
| 0.69 | OSL | Oncosil Medical | PairCorr |
| 0.55 | ALRS | Alerus Financial Corp | PairCorr |
| 0.53 | WFC-PL | Wells Fargo | PairCorr |
| 0.51 | BAC-PL | Bank of America | PairCorr |
| 0.49 | WF | Woori Financial Group | PairCorr |
The ability to find closely correlated positions to Medpace Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medpace Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medpace Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medpace Holdings to buy it.
The correlation of Medpace Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medpace Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medpace Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medpace Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.